CN1771974A - Application of hedgedog fungus mycelium oligose in preparing medicine - Google Patents
Application of hedgedog fungus mycelium oligose in preparing medicine Download PDFInfo
- Publication number
- CN1771974A CN1771974A CN 200510017252 CN200510017252A CN1771974A CN 1771974 A CN1771974 A CN 1771974A CN 200510017252 CN200510017252 CN 200510017252 CN 200510017252 A CN200510017252 A CN 200510017252A CN 1771974 A CN1771974 A CN 1771974A
- Authority
- CN
- China
- Prior art keywords
- bull
- pers
- oligosaccharide
- hericium erinaceus
- filament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The application of hedgedog fungus mycelium oligose in preparing medicine relates to the use of hedgedog fungus mycelium oligose. The hedgedog fungus mycelium fermenting extractum is processed through dilution with water and via stirring, centrifuging, adding alcohol to the centrifuged liquid, centrifuging to collect precipitate, adding distilled water to compound solution, dialysis of the solution to collect dialyzed outer liquid, concentration to obtain the hedgedog fungus mycelium oligose. The present invention has determined effective parts, clear structure, small dosage and obvious curative effect on acute and chronic gastritis, gastric ulcer and chronic atrophic gastritis.
Description
Technical field:
The present invention relates to the purposes of Hericium erinaceus (Bull. Ex Fr.) Pers. filament oligosaccharide, relate in particular to the purposes in pharmaceutical field.
Background technology:
The alleged Hericium erinaceus (Bull. Ex Fr.) Pers. filament (Hericium erinocens (Bull) eers) of the present invention is the tunning of Small acupuncture Hericium erinaceus (Bull. Ex Fr.) Pers.. its mycelium extractum is applied to clinical for many years as crude drug.
Cultivating extractum with Hericium erinaceus (Bull. Ex Fr.) Pers. filament on the China market is that the medicine that raw material is made has WEILEXIN CHONGJI.Although said preparation demonstrates good curative effect to stomach, duodenal ulcer, chronic gastritis etc., but the problems such as basic chemical composition to extraction, separation, purification process and the active component of effective ingredient in the mycelium are not resolved yet, are restricting the development and utilization of Hericium erinaceus (Bull. Ex Fr.) Pers. filament for a long time always.
Obtained the Hericium erinaceus (Bull. Ex Fr.) Pers. filament oligosaccharide by extraction, separation, purification to effective ingredient in the Hericium erinaceus (Bull. Ex Fr.) Pers. filament, its basic chemical structure is:
The HPGPC analysis result shows that the molecular weight distribution of this chemical compound is in 0.36-1.5 * 10
3, illustrate that this chemical compound is mainly the oligosaccharide constituents; Physicochemical property result shows that the content of sugar accounts for about 90%; Form the glycan analysis result and show, this chemical compound is mainly by Man, and two kinds of monosaccharide of Glc are formed, and mol ratio is 1: 5; Liquid-matter result shows that this chemical compound mainly is made of the oligosaccharide that 2-7 monosaccharide connects, and wherein disaccharidase and trisaccharide respectively account for about 20%, and other is tetrose, pentasaccharides, six sugar and seven sugar, also has a spot of monosaccharide.Disaccharidase, tetrose, pentasaccharides all have two kinds of configurations, and six sugar have three kinds of configurations, and trisaccharide and seven sugar have a kind of configuration.Adopt the HPLC method, two pools, trisaccharide that the nh 2 column purifies and separates obtains, utilize NMR, LC-MS, GG-MS, GC and methylation analysis infer that disaccharidase is that (or a-Manl → 6Glc) two kinds of forms exist, and to be α exist with-Glcl → 4 α-Glcl → 6a-Glc form trisaccharide with α-Glcl → 4a-Glc and a-Glcl → 6Man.
Summary of the invention:
The technical problem to be solved in the present invention provides the purposes of Hericium erinaceus (Bull. Ex Fr.) Pers. filament oligosaccharide, i.e. application in pharmacy.
In fact the invention provides the Hericium erinaceus (Bull. Ex Fr.) Pers. filament oligosaccharide as the application in the medicine of preparation treatment disease of stomach.
In order to understand the present invention better, provide the extracting method of Hericium erinaceus (Bull. Ex Fr.) Pers. filament oligosaccharide below, and pharmacological testing illustrates its purposes in pharmaceutical field.
Method 1
With the Hericium erinaceus (Bull. Ex Fr.) Pers. filament extractum 10k8 that ferments, add water 1-2 and doubly dilute, stir, centrifugal, centrifugal liquid adds ethanol to determining alcohol and is 80%, and is centrifugal, collecting precipitation, adding distil water is made into aqueous solution, to the dialysis of dialyzer molecular weight ranges 8,000-10,000 water, collect extracellular fluid dialysis, be concentrated into extractum 1kg, lyophilization gets Hericium erinaceus (Bull. Ex Fr.) Pers. filament oligosaccharide 800g.
Method 2
Get hericium mycelium fermentation extractum 10kg, add water 1-2 and doubly dilute, stir, centrifugal, centrifugal liquid adds ethanol to determining alcohol and is 80%, and is centrifugal, collecting precipitation 1kg, adding distil water is made into aqueous solution, by the DEAE-SephadexA50 ion exchange resin column, uses the distilled water eluting respectively, collect eluent, be concentrated into extractum, lyophilization gets Hericium erinaceus (Bull. Ex Fr.) Pers. filament oligosaccharide 780g.
Method 3
Get hericium mycelium fermentation extractum 10kg, add water 1-2 and doubly dilute, stir, centrifugal, centrifugal liquid adds ethanol to determining alcohol and is 80%, and is centrifugal, collecting precipitation 1kg, and adding distil water is made into aqueous solution.At 8,000-10,000 Hollow Fiber Ultrafiltration, obtain oligosaccharide 800g by molecular weight ranges.
Through the pharmacological experiment screening, above-claimed cpd has the acute and chronic gastritis of treatment, gastric ulcer, chronic atrophic gastritis effect.
Press practice of pharmacy, the Hericium erinaceus (Bull. Ex Fr.) Pers. filament oligosaccharide can prepare various clinical pharmaceutical preparation as the acute and chronic gastritis of treatment, gastric ulcer, the medicine of chronic atrophic gastritis, said medicament is a said dosage form on any pharmaceutics, particularly as various peroral dosage forms.
It is active component that medicine of the present invention contains the above-claimed cpd for the treatment of effective dose, and contains one or more pharmaceutically acceptable carriers.
Carrier above is meant that the medicine of pharmaceutical field routine carries not, comprises diluent, figuration punishment, filler, binding agent, wetting agent, disintegrating agent, absorption enhancer, surfactant, absorption carrier.
Medicine of the present invention can be applied to the patient of this treatment by oral, rectum, vein, intramuscular injection or parenteral mode.Conventional production method according to pharmaceutical field prepares various dosage forms such as tablet, granule, electuary, capsule, suppository, spray, slow releasing agent and injection.Also can make its active component or compositions and variety carrier or medicament mixed, make required dosage form.
Following pharmacological evaluation has confirmed that the pharmaceutical preparation of Hericium erinaceus (Bull. Ex Fr.) Pers. filament oligosaccharide has the acute and chronic gastritis of treatment, gastric ulcer, the pharmacologically active of chronic atrophic gastritis.
One, Hericium erinaceus extract is to the influence of damage type gastric ulcer due to the acetic acid
Summary: this laboratory observation Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide is to the influence of damage type gastric ulcer rat due to the acetic acid.The continuous irrigation stomach gave due to the acetic acid damage type gastric ulcer rat 480mg/kg Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide 14 days respectively, and damage type gastric ulcer due to the acetic acid is all had significant inhibitory effect.
Medicine: positive drug is a WEILEXIN, thinks medical university's pharmaceutical factory production, lot number: 041205 by asking in vain.
Animal: 220-260g male rat.Available from 208 animal housing of hospital of the Chinese People's Liberation Army.
Method: get the rat fasting and can't help water 48 hours, etherization, it is fixing to face upward the position, abdominal part unhairing, iodine tincture, alcohol disinfecting, xiphoid-process hits exactly the otch of opening about 2.5cm down, duodenum is ticked gently below right liver with curved hemostat, stomach is pulled out outside the abdomen gently, at the facies ventralis body of stomach and the pyloric antrum intersection of stomach, thrust 0.4-0.5mm under the rat stomach serous coat with the 0.25ml syringe, inject 10% acetum 0.05ml, stomach is sent back to gently, sew up abdominal muscle and skin, the sterilization back is conventional raises, Rhizoma Atractylodis Macrocephalae rises next day, grouping, successive administration 14 days, last administration 2h, broken end, ligation pylorus and cardia, stomach are dipped in 1% formalin, fix 10 minutes, cut off along greater gastric curvature, the washing of turning up is observed the ulcer situation at the mucosal surface of injection acetum corresponding site, as the ulcer diameter, calculate ulcer index with the average of major diameter of ulcer and minor axis.See Table.
Table. the Hericium erinaceus polysaccharide extract is to the influence of damage type gastric ulcer due to the acetic acid
| Group | Dosage mg/kg | Ulcer diameter mm | Ulcer healing percentage rate % |
| The positive group of model group Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide | 480 480 240 | 5.13±1.13 3.63±1.39※ 3.46±0.89※※※ 4.04±1.09※ | 29.24 32.55 21.25 |
Annotate: n=8, X ± SD.※P＜0.05，※※※P＜0.001。
Brief summary: 480mg/kg Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide 14 days all has significant inhibitory effect to damage type gastric ulcer due to the acetic acid.480mg/kg is especially remarkable to the inhibitory action of damage type gastric ulcer due to the acetic acid.
Two, Hericium erinaceus extract is to the influence of stress gastric ulcer
Summary: adopt the stress gastric ulcer model to compare the antiulcer action of Hericium erinaceus polysaccharide extract and WEILEXIN.
The continuous irrigation stomach gives rat 480mg/kg Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide 15 days respectively, and the Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide has tangible antiulcer action as a result.
Animal: 32 of Wister rats, think animal housing of medical university available from asking in vain.
Medicine: positive drug is a WEILEXIN, thinks medical university's pharmaceutical factory production, lot number: 041205 by asking in vain.
Method: get 50 of rats, be divided into 5 groups at random, 10 every group, irritate every day stomach give 480mg/kg Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide and WEILEXIN each once, matched group gives ordinary water, give 15 days continuously, with the hungry 32h of rat, at 16 o'clock the next afternoon was used etherization after the administration in the 14th day, the rat extremity are tied up on the ferrum cage with fly, the rat that to tie up is vertically placed 18h upside down simultaneously, draws neck to put to death animal.With the cardia and the pylorus ligation of its stomach, get full stomach, and after inwardly injecting 1% formalin fixed 5min, cut off along greater gastric curvature, lie on glass and pull, observe and judge grade.
The result: matched group is 3.87 ± 0.35, and 480mg/kg Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide is 2.38 ± 1.51 (P＜0.05), and WEILEXIN is 2.13 ± 1.13 (P＜0.001).
This shows that the Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide has very significantly antiulcer action.
Three, Hericium erinaceus extract is to rat chronic atrophic gastritis experimentation
Summary: the employing active immunity adds the integrated approach that gavages bile and hot water and observes the therapeutical effect of Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide to rat chronic atrophic gastritis CAG, the result: X mg/kgHl, X mg/kgL2 can obviously improve the attenuation of CAG gastric mucosa of rat, and the intrinsic body of gland of gastric mucosa is increased, the effect of good curing CAG is arranged.
Key word: chronic atrophic gastritis CAG, Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide.
1. experiment material and method:
1.1 animal: the Wistar male rat, available from Changchun High-technology Medical Animal Experiment Research Center, qualified 10-5112, body weight 220-260g.
1.2 medicine: positive drug is a WEILEXIN, is produced lot number: 041205 by Bethune medical university pharmaceutical factory.
1.3 Preparation of model:
1.3.1 the antigenic preparation of adjuvant: get the 160-180gWistar rat, get gastric mucosa with putting to death behind its hungry 24h, every Mus gastric mucosa adds normal saline 3ml, utilizes tissue refiner that its dozen is even, add the equal-volume white oil then and be prepared into uniform Emulsion, standby.
1.3.2 Preparation of model: get 90 of 220-260g rats, at 2 backs of every rat subcutaneous injection adjuvant antigen 2ml, every some 1ml, 2 week back repetitions 1 time repeat again after 1 week 1 time again, and immunity is 3 times altogether; Gavage only (bile: glycerol=1: 1) of Fel Sus domestica 2ml/ for the people Mus from immunity every 3 days; Simultaneously ought be beyond the highest heavens except that gavaging Fel Sus domestica, gavage 35 days 55 ℃ of hot water every day continuously.
1.3.3 animal is handled: first immunisation was put to death 10 rats in 35 days and is got stomach and make tectology and detect, visible gastric mucosa body of gland attenuation, and the gastric gland body reduces, and as seen indivedual stomaches have a large amount of cellular infiltrations under ulcer, hemorrhage, the mucosa.
1.3.4 grouping and administration: remaining rat is divided into six groups at random, and promptly model control group only gives ordinary water 4ml/ every day, the 480mg/kg WEILEXIN, and 480mg/kg Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide, administration every day 1 time, successive administration 30 days, and in weighing weekly 1 time.
1.3.5 to the influence that changes in the pathology of gastric mucosa tissue: animal curved is drawn materials embedded section to cardia from gastric antrum along little.Adopt the x2 check.
2. result:
2.1 influence to the gastric mucosa tectology:
From subordinate list and table 2 as seen, the negative rate of phenomenons such as the attenuation of model group gastric mucosa, body of gland minimizing is still apparently higher than the administration group, and thickens and the Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide all has the obvious suppression effect to above-mentioned phenomenon and do not see that the flesh layer thickens phenomenon from the flesh layer with a large amount of cell infiltration.
2.2 the influence to the variation of chronic atrophic gastritis rat body weight: see Table 3
Table 2. shows that the variation of chronic atrophic gastritis rat body weight is not had influence.
Brief summary: The above results shows that the Hericium erinaceus (Bull. Ex Fr.) Pers. glycoprotein has certain therapeutical effect to the rat chronic atrophic gastritis.
The table 1. pair morphologic influence of chronic atrophic gastritis mucosa tissue
| Group | Dosage mg/kg | Number of animals only | Gastric mucosa attenuation feminine gender | The minimizing feminine gender of gastric gland | The congestion of blood vessel or hemorrhage feminine gender |
| Model control group positive drug Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide | 480 480 240 | 10 12 10 12 | 9 2* 2* 4* | 10 5 2* 5 | 7 4 4 6 |
Annotate: with table 1.
The influence that table 2. pair chronic atrophic gastritis rat body weight changes
| Group | Dosage mg/kg | Number of animals only | Body weight change | ||||
| 0 week | 1 week | 2 weeks | 3 weeks | 4 weeks | |||
| Model control group | 12 | 256.6±18.6 | 262.8±17.9 | 281.0±25.5 | 280.4±27.0 | 283.7±27.3 | |
| Positive drug Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide | 480 480 240 | 12 12 12 | 257.9±17.5 254.1±19.1 262.8±17.7 | 264.4±22.5 271.6±25.0 280.2±26.3 | 274.5±23.2 278.4±29.3 291.8±27.3 | 275.3 ± 23.4 275.3 ± 32.2 281.6 soil 249 | 280.9±24.0 283.7±31.7 290.6±29.5 |
Can draw from above result and the invention has the advantages that: effective site is clear and definite, and structure is clear, and dose is few, for the acute and chronic gastritis of treatment, and gastric ulcer, chronic atrophic gastritis has significant curative effect.And be better than positive control drug.
The specific embodiment:
Embodiment 1
With the Hericium erinaceus (Bull. Ex Fr.) Pers. filament extractum 10kg that ferments, add water 1-2 and doubly dilute, stir, centrifugal, centrifugal liquid adds ethanol to determining alcohol and is 80%, and is centrifugal, collecting precipitation, adding distil water is made into aqueous solution, and dialyzer molecular weight ranges 8,000-10,000 water is dialysed, collect extracellular fluid dialysis, be concentrated into extractum 1kg, lyophilization gets powdery Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide 800g, packing into seals in the medicine bottle, and product is made in sterilization.
Embodiment 2
Get hericium mycelium fermentation extractum 10kg, add water 1-2 and doubly dilute, stir, centrifugal, centrifugal liquid adds ethanol to determining alcohol and is 80%, and is centrifugal, collecting precipitation 1kg, adding distil water is made into aqueous solution, by the DEAE-SephadexA50 ion exchange resin column, use the distilled water eluting respectively, collect eluent, be concentrated into extractum, lyophilization gets Hericium erinaceus (Bull. Ex Fr.) Pers. oligosaccharide 780g, makes XXX, packing into seals in the medicine bottle, and product is made in sterilization.
Embodiment 3
Get hericium mycelium fermentation extractum 10kg, add water 1-2 and doubly dilute, stir, centrifugal, centrifugal liquid adds ethanol to determining alcohol and is 80%, and is centrifugal, collecting precipitation 1kg, and adding distil water is made into aqueous solution.At 8,000-10,000 Hollow Fiber Ultrafiltration, obtain oligosaccharide 800g by molecular weight ranges, make XXX, seal in the medicine bottle of packing into, product is made in sterilization.
Claims (7)
1, the application of Hericium erinaceus (Bull. Ex Fr.) Pers. filament oligosaccharide in the medicine of preparation treatment disease of stomach.
2, the application of Hericium erinaceus (Bull. Ex Fr.) Pers. filament oligosaccharide in the medicine of preparation treatment gastritis disease.
3, the application of Hericium erinaceus (Bull. Ex Fr.) Pers. filament oligosaccharide in the medicine of preparation treatment gastric ulcer.
4, the application of Hericium erinaceus (Bull. Ex Fr.) Pers. filament oligosaccharide in the medicine of preparation treatment chronic atrophic gastritis disease.
5, a kind of extracting method of Hericium erinaceus (Bull. Ex Fr.) Pers. filament oligosaccharide with the Hericium erinaceus (Bull. Ex Fr.) Pers. filament extractum 10k8 that ferments, adds water 1-2 and doubly dilutes, stir, centrifugal, it is 80% that centrifugal liquid adds ethanol to determining alcohol, centrifugal, collecting precipitation, adding distil water is made into aqueous solution, and dialyzer molecular weight ranges 8,000-10,000 water is dialysed, collect extracellular fluid dialysis, be concentrated into extractum 1kg, lyophilization gets Hericium erinaceus (Bull. Ex Fr.) Pers. filament oligosaccharide 800g.
6, a kind of extracting method of Hericium erinaceus (Bull. Ex Fr.) Pers. filament oligosaccharide is got hericium mycelium fermentation extractum 10kg, adds water 1-2 and doubly dilutes, stir, centrifugal, it is 80% that centrifugal liquid adds ethanol to determining alcohol, centrifugal, collecting precipitation 1kg, adding distil water is made into aqueous solution, by the DEAE-SephadexA50 ion exchange resin column, use the distilled water eluting respectively, collect eluent, be concentrated into extractum, lyophilization gets the Hericium erinaceus (Bull. Ex Fr.) Pers. filament oligosaccharide.
7, a kind of extracting method of Hericium erinaceus (Bull. Ex Fr.) Pers. filament oligosaccharide is got hericium mycelium fermentation extractum 10kg, adds water 1-2 and doubly dilutes, and stirs, and centrifugal, centrifugal liquid adds ethanol to determining alcohol and is 80%, and is centrifugal, collecting precipitation 1kg, and adding distil water is made into aqueous solution.At 8,000-10,000 Hollow Fiber Ultrafiltration, obtain the Hericium erinaceus (Bull. Ex Fr.) Pers. filament oligosaccharide by molecular weight ranges.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510017252 CN1771974A (en) | 2005-11-02 | 2005-11-02 | Application of hedgedog fungus mycelium oligose in preparing medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510017252 CN1771974A (en) | 2005-11-02 | 2005-11-02 | Application of hedgedog fungus mycelium oligose in preparing medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1771974A true CN1771974A (en) | 2006-05-17 |
Family
ID=36759228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510017252 Pending CN1771974A (en) | 2005-11-02 | 2005-11-02 | Application of hedgedog fungus mycelium oligose in preparing medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1771974A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111892663A (en) * | 2020-07-22 | 2020-11-06 | 湖北民族大学 | Hericium erinaceus polysaccharide and preparation method and application thereof |
| CN113336868A (en) * | 2021-06-10 | 2021-09-03 | 吉林农业大学 | Hericium erinaceus mycelium polysaccharide with effect of preventing and treating senile dementia and preparation method thereof |
-
2005
- 2005-11-02 CN CN 200510017252 patent/CN1771974A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111892663A (en) * | 2020-07-22 | 2020-11-06 | 湖北民族大学 | Hericium erinaceus polysaccharide and preparation method and application thereof |
| CN111892663B (en) * | 2020-07-22 | 2022-10-25 | 湖北民族大学 | Hericium erinaceus polysaccharide and preparation method and application thereof |
| CN113336868A (en) * | 2021-06-10 | 2021-09-03 | 吉林农业大学 | Hericium erinaceus mycelium polysaccharide with effect of preventing and treating senile dementia and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100344642C (en) | Process for preparing flaxseed lignan total glycoside extract and use thereof | |
| CN101375867B (en) | Oligosaccharide of mycelium of Hericium erinaceus extracted from fermentation product of mycelium of Hericium erinaceus and uses thereof | |
| CN1771974A (en) | Application of hedgedog fungus mycelium oligose in preparing medicine | |
| CN1772287A (en) | Application of hedgehog fungus mycelium glucoprotein in preparing medicine | |
| CN1686377A (en) | Chuankezhi (pant treating) powder injection and its preparation method | |
| CN101306014A (en) | Use of brown algae polysaccharide sulfuric acid ester of low molecular weight in preparing medicine for treating diabetic nephropathy | |
| CN1147303C (en) | Application of Breviscapine in preparing medicine | |
| CN108165499A (en) | A kind of culture medium of Hericium erinaceus, Chinese yam bioconversion mycelium, the mycelial extract of Chinese yam bioconversion and application thereof | |
| US9782431B2 (en) | Method to prepare hirsutella sinensis polysaccharides possessing anti-obesity properties and uses thereof | |
| CN1839855A (en) | Ginsenoside F1 medicinal uses | |
| CN1560061A (en) | Process for extracting dioscored soap oside from dioscorea | |
| CN1698803A (en) | Compound notoginseng injection and its preparation process | |
| CN1895275A (en) | Calf-blood deprotein extract gel | |
| CN1248698C (en) | Drug for treating coronary heart disease or coronary disease and cardiac insufficiency, and its preparation method | |
| CN1857466A (en) | Chinese medicine injection for treating cardiac vascular disease and its preparing method | |
| CN101375866A (en) | Chinese medicinal composition for treating disease of stomach | |
| CN1895458A (en) | Compound Chinese-medicinal extract for treating gynaopathy and its preparation | |
| CN1623557A (en) | Application of gold ear mycelium polysaccharide for lowering blood fat and blood sugar | |
| CN101284032A (en) | Delicate fragrance vine formulations and preparation method thereof | |
| CN1283246C (en) | Complex rheum officinale-radix scutellariae extract injecta for treating acute pancreatitis and preparing method thereof | |
| CN1562111A (en) | Use of cassia sophera stem and leaf extract in preparing medicine for treating diabetes and improving its symptom | |
| CN1256942C (en) | Application of dihydromyricetrin | |
| CN115957249A (en) | Application of tripterygium wilfordii bidirectional solid fermentation product in preparation of medicine for treating kidney disease | |
| CN1267095C (en) | Application use of dihydromyricetrin | |
| CN1788742A (en) | Ciliate desert-grass effective parts and allergy-resistant use of effective ingredient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |